Postgraduate Medicine
Volume 133, 2021 - Issue 1
Open access
5,468
Views
24
CrossRef citations to date
0
Altmetric
Clinical Features - <italic>Original Research</italic>
Lack of residual morning effects of lemborexant treatment for insomnia: summary of findings across 9 clinical trials
Margaret Molinea Neurobiology Business Group, Eisai Inc., Woodcliff Lake, New Jersey, USACorrespondence[email protected]
https://orcid.org/0000-0003-0807-2167
Gary Zammitb Clinilabs Drug Development Corporation, New York, New York, USA
https://orcid.org/0000-0001-8332-6687
Jane Yardleyc Neurobiology Business Group, Eisai Ltd., Hatfield, UK
https://orcid.org/0000-0001-8198-4328
Kate Pinnerc Neurobiology Business Group, Eisai Ltd., Hatfield, UK
https://orcid.org/0000-0002-3475-2708
Dinesh Kumara Neurobiology Business Group, Eisai Inc., Woodcliff Lake, New Jersey, USA
https://orcid.org/0000-0001-5880-4237
Carlos Perdomoa Neurobiology Business Group, Eisai Inc., Woodcliff Lake, New Jersey, USA
https://orcid.org/0000-0001-9307-1833
Jocelyn Y. Chenga Neurobiology Business Group, Eisai Inc., Woodcliff Lake, New Jersey, USA
https://orcid.org/0000-0001-5318-5668
Pages 71-81
|
Received 12 Jul 2020, Accepted 11 Sep 2020, Published online: 29 Oct 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.